Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
07/2014
07/01/2014US8765153 Levalbuterol salt
07/01/2014US8765152 Pharmaceutical or neutraceutical formulation
07/01/2014US8765150 Riluzole aqueous suspensions
07/01/2014US8765149 Low-oil pharmaceutical emulsion compositions comprising progestogen
07/01/2014US8765119 Treating amyotrophic lateral sclerosis (ALS)with isolated aldehyde dehydrogenase-positive umbilical cord blood cells
07/01/2014US8765112 Thermal responsive polymer siloxanes, compositions, and method and applications related thereto
07/01/2014US8765111 N-maleimidyl polymer derivatives
07/01/2014US8765110 Composition containing an alkoxysilane and hyaluronic acid
07/01/2014US8765100 Transmucosal effervescent
06/2014
06/28/2014CA2800186A1 Nutritional formulations and method for treating diseases
06/26/2014WO2014100834A1 Methods and compositions for treatment of cyanide and hydrogen sulfide toxicity
06/26/2014WO2014100833A1 Benzamide compounds and related methods of use
06/26/2014WO2014100807A1 Antimicrobial bispyridine amine compositions and uses
06/26/2014WO2014100777A2 Antimicrobial compositions
06/26/2014WO2014100767A1 Isoquinolinone or quinazolinone phosphatidylinositol 3-kinase inhibitors
06/26/2014WO2014100765A1 Substituted pyrimidine aminoalkyl-quinazolones as phosphatidylinositol 3-kinase inhibitors
06/26/2014WO2014100762A1 Hydrophilic self-immolative linkers and conjugates thereof
06/26/2014WO2014100735A2 Diazole amides
06/26/2014WO2014100734A1 Prmt5 inhibitors and uses thereof
06/26/2014WO2014100733A1 Methods and materials for treating calcific aortic valve stenosis
06/26/2014WO2014100730A1 Prmt5 inhibitors containing a dihydro- or tetrahydroisoquinoline and uses thereof
06/26/2014WO2014100728A1 Deuterium substituted fumarate derivatives
06/26/2014WO2014100714A1 Improved exon skipping compositions for treating muscular dystrophy
06/26/2014WO2014100703A2 Method for treating diastolic heart failure by inhibiting galectin-3
06/26/2014WO2014100700A1 Cytoprotective derivatives of avicin d and methods of making and using thereof
06/26/2014WO2014100696A1 Nutritional formulations using human milk oligosaccharides for modulating inflammation
06/26/2014WO2014100679A1 Stimulation and enhancement of regeneration of tissues
06/26/2014WO2014100665A1 1,4-pyridone bicyclic heteroaryl compounds
06/26/2014WO2014100662A1 Dot1 l inhibitors for use in the treatment of leukemia
06/26/2014WO2014100646A1 1,4-pyridone compounds
06/26/2014WO2014100643A1 Oral transmucosal delivery of glatiramer acetate
06/26/2014WO2014100639A1 Transmucosal delivery of glatiramer acetate
06/26/2014WO2014100636A2 Methods of treating atherosclerosis or myeloproliferative neoplasms by administering a lyn kinase activator
06/26/2014WO2014100624A1 Stable liquid remifentanil formulations
06/26/2014WO2014100615A1 Chimeric antigen receptor-expressing t cells as anti-cancer therapeutics
06/26/2014WO2014100599A1 Compositions and methods for transdermal delivery of hormones and other medicinal agents
06/26/2014WO2014100569A1 High dosage topical metronidazole gel formulations
06/26/2014WO2014100565A1 Methods and compositions relating to treatment of cancer
06/26/2014WO2014100541A1 Substituted pyridine-2-carboxamide compounds as apoptosis signal-regulating kinase inhibitors
06/26/2014WO2014100540A1 Pyrazole substituted imidazopyrazines as casein kinase 1 d/e inhibitors
06/26/2014WO2014100533A1 NOVEL SUBSTITUTED IMIDAZOLES AS CASEIN KINASE 1 δ/ε INHIBITORS
06/26/2014WO2014100505A1 Substituted nucleosides, nucleotides and analogs thereof
06/26/2014WO2014100501A1 Small molecule agonists of neurotensin receptor 1
06/26/2014WO2014100500A1 Antiviral compounds
06/26/2014WO2014100498A1 Substituted nucleosides, nucleotides and analogs thereof
06/26/2014WO2014100486A1 Artemisinin compounds and synthesis and use thereof
06/26/2014WO2014100463A1 Histone demethylase inhibitors
06/26/2014WO2014100438A1 Cycloalkenyl hydroxamic acid derivatives and their use as histone deacetylase inhibitors
06/26/2014WO2014100431A1 Deuterated alk inhibitors
06/26/2014WO2014100425A1 Peri-carbinols
06/26/2014WO2014100417A1 Compounds, compositions, and methods for the treatment of cancers
06/26/2014WO2014100367A1 Synthesis of fr901464 and analogs with antitumor activity
06/26/2014WO2014100359A1 Novel ergoline derivatives and uses thereof
06/26/2014WO2014100357A1 Fluoroergoline derivatives and uses thereof
06/26/2014WO2014100354A1 Novel methysergide derivatives
06/26/2014WO2014100353A1 8'-hydroxy-dihydroergotamine compounds and compositions
06/26/2014WO2014100352A1 Method for treatment of diseases
06/26/2014WO2014100314A1 Thiazole-substituted aminopyridines as spleen tyrosine kinase inhibitors
06/26/2014WO2014100292A1 Treatment of circadian rhythm disorders
06/26/2014WO2014100231A1 Use of cannabinoids and terpenes for treatment of organophosphate and carbamate toxicity
06/26/2014WO2014100228A1 Neuroactive 19-alkoxy-17-substituted steroids, prodrugs thereof, and methods of treatment using same
06/26/2014WO2014100227A1 Transthyretin stabilizers and their use for inhibiting transthyretin amyloidosis and protein-protein interactions
06/26/2014WO2014100225A1 Nutritional use of human milk oligosaccharides
06/26/2014WO2014100191A1 Nutritional compositions comprising neuroprotective dietary oligosaccharides
06/26/2014WO2014100158A1 Mannose derivatives for treating bacterial infections
06/26/2014WO2014100135A1 Lfa-1 inhibitor formulations
06/26/2014WO2014100126A1 Human milk oligosaccharides to ameliorate symptoms of stress
06/26/2014WO2014100113A2 Syk kinase inhibitors as treatment for malaria
06/26/2014WO2014100080A1 Combination
06/26/2014WO2014100071A2 Substituted pyrrolopyrimidines as hdm2 inhibitors
06/26/2014WO2014100069A1 POST-SYNTHETIC ORTHOGONAL AMIDATION PLUS METAL CATALYZED AZIDE-ALKYNE CYCLOADDITION CLICK CHEMISTRY ON siRNA
06/26/2014WO2014100065A1 Substituted imidazopyridines as hdm2 inhibitors
06/26/2014WO2014100025A1 Tgr5 agonists having an imidazole or triazole core with subtituent having a quaternary nitrogen
06/26/2014WO2014100022A1 Dietary oligosaccharides to enhance learning and memory
06/26/2014WO2014100021A1 Tgr5 agonists: imidazole and triazole compounds containing a quaternary nitrogen
06/26/2014WO2014099941A1 4'-fluoro nucleosides for the treatment of hcv
06/26/2014WO2014099904A1 Methods for enhancing motor function, enhancing functional status and mitigating muscle weakness in a subject
06/26/2014WO2014099900A1 Composition and methods for treating or preventing lung diseases
06/26/2014WO2014099880A1 Aryl-substituted fused bicyclic pyridazine compounds
06/26/2014WO2014099837A1 Sulfonamide anthelmintics
06/26/2014WO2014099836A1 Spirocyclic cetp inhibitors
06/26/2014WO2014099834A1 Therapeutic thiazolidinone compounds
06/26/2014WO2014099833A1 Indazole compounds as aldosterone synthase inhibitors
06/26/2014WO2014099794A1 C5, c6 oxacyclic-fused iminothiazine dioxide compounds as bace inhibitors
06/26/2014WO2014099788A1 C5-spiro iminothiadiazine dioxides as bace inhibitors
06/26/2014WO2014099768A1 C6-azaspiro iminothiadiazine dioxides as bace inhibitors
06/26/2014WO2014099705A1 Arylalkyl-and aryloxyalkyl-substituted epithelial sodium channel blocking compounds
06/26/2014WO2014099698A1 2-pyridyloxy-3-nitrile-4-substituted orexin receptor antagonists
06/26/2014WO2014099697A1 3-ester-4-substituted orexin receptor antagonists
06/26/2014WO2014099696A1 2-pyridyloxy-4-ester orexin receptor antagonists
06/26/2014WO2014099695A1 Factor ixa inhibitors
06/26/2014WO2014099694A1 FACTOR IXa INHIBITORS
06/26/2014WO2014099686A2 Methods of treating gastrointestinal spasms
06/26/2014WO2014099676A1 Chloro-pyrazine carboxamide derivatives useful for the treatment of diseases favoured by insufficient mucosal hydration
06/26/2014WO2014099673A1 3,5-diamino-6-chloro-n-(n-(4-phenylbutyl)carbamimidoyl) pyrazine-2- carboxamide compounds
06/26/2014WO2014099633A2 Inhibitors of the renal outer medullary potassium channel
06/26/2014WO2014099503A1 Triazolone compounds and uses thereof
06/26/2014WO2014099461A1 Antimicrobial compositions
06/26/2014WO2014099115A1 Collagen stimulators and their use in the treatment of skin
06/26/2014WO2014099112A1 Collagen stimulators and their use in the treatment of skin
1 ... 213 214 215 216 217 218 219 220 221 222 223 224 225 226 227 228 229 230 231 232 233 ... 7860